Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 5:13:917056.
doi: 10.3389/fendo.2022.917056. eCollection 2022.

The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study

Yang Yang  1 , Wei Xian  1 , Dide Wu  1 , Zijun Huo  1 , Shubin Hong  1 , Yanbing Li  1 , Haipeng Xiao  1
Affiliations

The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study

Yang Yang et al. Front Endocrinol (Lausanne). .

Abstract

Background: Several epidemiological studies have reported a possible correlation between risk of gout and metabolic disorders including type 2 diabetes, insulin resistance, obesity, dyslipidemia, and hypertension. However, it is unclear if this association is causal.

Methods: We used Mendelian randomization (MR) to evaluate the causal relation between metabolic conditions and gout or serum urate concentration by inverse-variance-weighted (conventional) and weighted median methods. Furthermore, MR-Egger regression and MR-pleiotropy residual sum and outlier (PRESSO) method were used to explore pleiotropy. Genetic instruments for metabolic disorders and outcome (gout and serum urate) were obtained from several genome-wide association studies on individuals of mainly European ancestry.

Results: Conventional MR analysis showed a robust causal association of increasing obesity measured by body mass index (BMI), high-density lipoprotein cholesterol (HDL), and systolic blood pressure (SBP) with risk of gout. A causal relationship between fasting insulin, BMI, HDL, triglycerides (TG), SBP, alanine aminotransferase (ALT), and serum urate was also observed. These results were consistent in weighted median method and MR-PRESSO after removing outliers identified. Our analysis also indicated that HDL and serum urate as well as gout have a bidirectional causal effect on each other.

Conclusions: Our study suggested causal effects between glycemic traits, obesity, dyslipidemia, blood pressure, liver function, and serum urate as well as gout, which implies that metabolic factors contribute to the development of gout via serum urate, as well as potential benefit of sound management of increased serum urate in patients with obesity, dyslipidemia, hypertension, and liver dysfunction.

Keywords: Mendelian randomization; causal relationship; gout; metabolic factors; urate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Forest plot of Mendelian randomization analyses for the genetical associations of glycemic traits, obesity, blood lipid, blood pressure, and liver function with increased serum urate. CI, confidence interval; SNP, single-nucleotide polymorphism.
Figure 2
Figure 2
Forest plot of Mendelian randomization analyses for the genetical associations of glycemic traits, obesity, blood lipid, blood pressure, and liver function with risk of gout. CI, confidence interval; SNP, single-nucleotide polymorphism; OR, odds ratio.
See this image and copyright information in PMC

References

    1. Richette P, Bardin T. Gout. Lancet (London England) (2010) 375:318–28. doi: 10.1016/s0140-6736(09)60883-7 - DOI - PubMed
    1. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol (2015) 11:649–62. doi: 10.1038/nrrheum.2015.91 - DOI - PubMed
    1. Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. . Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (London England) (2008) 372:1953–61. doi: 10.1016/s0140-6736(08)61343-4 - DOI - PMC - PubMed
    1. Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. . SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet (2008) 40:430–6. doi: 10.1038/ng.107 - DOI - PubMed
    1. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet (London England) (2016) 388:2039–52. doi: 10.1016/s0140-6736(16)00346-9 - DOI - PubMed